<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=405009060588537&amp;ev=PageView&amp;noscript=1">
steven-lewis-342-unsplash-v4
Clay Carter
Pfizer and the biosimilar opportunity

On March 6, 2015 the U.S. FDA approved Sandoz’s Zarxio (filgrastim), the..

Clay Carter
Splunk – investing in big data analytics

What is “Big Data”? Well, every day we create close to 3 exabytes of data...

Clay Carter
Three high performing social media stocks worth investing in

The Macrovue Social Media thematic portfolio, known as a ‘Vue’, has..

Clay Carter
Three cleantech stocks worth investing in

The Clean Technology Vue has generated a total return of +17.92% in the last..

Clay Carter
Car of the Future Quarterly Review April 2018

The Car of the Future Vue is a portfolio dedicated to investing in the..

Clay Carter
Technology Shares To Buy - Have The “FANG” Stocks Still Got Bite?

This article was featured on The Australian on 21st April, written by..

Clay Carter
Top 3 Agriculture Shares - Feed the World Vue Quarterly Review May 2018

The Feed the World Vue is a portfolio that includes companies which have..

Clay Carter
Best-performing Shares | Luxury Goods Vue Quarterly Review - May 2018

The Luxury Goods Vue is a concentrated share portfolio of high conviction..

More Posts